IMMX
Immix Biopharma, Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
25
Buys
24
Sells
1
Largest Trade
$100K–$500K
Insiders
8
Institutional Funds
47
Inst. Value
$1M+
Activist Filings
6
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Rachman Ilya M | CEO and Chairman | BUY | $1K–$15K | 746 | $6.67 | Dec 10, 2025 |
| Morris Gabriel S | CFO | BUY | $1K–$15K | 770 | $6.58 | Dec 10, 2025 |
| Rachman Ilya M | CEO and Chairman | BUY | $1K–$15K | 3K | $2.02 | Sep 17, 2025 |
| Morris Gabriel S | CFO | BUY | $1K–$15K | 3K | $1.97 | Sep 17, 2025 |
| Rachman Ilya M | CEO and Chairman | BUY | $1K–$15K | 2K | $2.29 | Jun 20, 2025 |
| Morris Gabriel S | CFO | BUY | $1K–$15K | 2K | $2.28 | Jun 20, 2025 |
| Hsu Jason | Director | BUY | $100K–$500K | 48K | $2.19 | Dec 26, 2024 |
| Hsu Jason | Director | BUY | $50K–$100K | 23K | $2.23 | Aug 26, 2024 |
| Ng Carey | Director | BUY | $15K–$50K | 10K | $1.86 | Aug 20, 2024 |
| Hsu Jason | Director | BUY | $15K–$50K | 9K | $2.12 | Aug 1, 2024 |
| Morris Gabriel S | CFO | BUY | $1K–$15K | 3K | $2.12 | Jun 10, 2024 |
| Rachman Ilya M | CEO and Chairman | BUY | $1K–$15K | 3K | $2.13 | Jun 10, 2024 |
| Morris Gabriel S | CFO | BUY | $1K–$15K | 3K | $1.81 | Jun 5, 2024 |
| Rachman Ilya M | CEO and Chairman | BUY | $1K–$15K | 3K | $1.81 | Jun 5, 2024 |
| Hsu Jason | Director | BUY | $100K–$500K | 72K | $2.78 | Sep 18, 2023 |
| Ng Carey | Director | BUY | $15K–$50K | 10K | $2.58 | Sep 15, 2023 |
| Adams Helen C. | Director | BUY | $15K–$50K | 13K | $2.96 | Sep 14, 2023 |
| Hsu Jason | Director | BUY | $15K–$50K | 10K | $2.53 | Sep 12, 2023 |
| BUCHAN MELISSA JANE | Director | BUY | $15K–$50K | 20K | $2.46 | Sep 11, 2023 |
| Marquet Magda | Director | BUY | $15K–$50K | 9K | $2.47 | Sep 8, 2023 |
| Marquet Magda | Director | BUY | $15K–$50K | 10K | $2.47 | Sep 6, 2023 |
| Marquet Magda | Director | BUY | $1K–$15K | 1K | $2.01 | Sep 5, 2023 |
| Rachman Ilya M | CEO and Chairman | BUY | $1K–$15K | 5K | $1.00 | Nov 15, 2022 |
| Morris Gabriel S | CFO | BUY | $1K–$15K | 5K | $0.94 | Nov 15, 2022 |
| Senn Sean | 10% Owner | SELL | <$1K | 200 | $2.75 | Jul 18, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 47 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 2.5M | $1M+ | SH |
| Bleichroeder LP | 1.0M | $1M+ | SH |
| Logos Global Management LP | 1.0M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 986K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 986K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 339K | $1M+ | SH |
| MARSHALL WACE, LLP | 312K | $1M+ | SH |
| Burkehill Global Management, LP | 294K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 259K | $1M+ | SH |
| KVP Capital Advisors, LP | 230K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 208K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 196K | $1M+ | SH |
| JANE STREET GROUP, LLC | 153K | $500K+ | SH |
| VANGUARD GROUP INC | 130K | $500K+ | SH |
| LGT Fund Management Co Ltd. | 125K | $500K+ | SH |
| Informed Momentum Co LLC | 121K | $500K+ | SH |
| J. Goldman & Co LP | 118K | $500K+ | SH |
| MORGAN STANLEY | 108K | $500K+ | SH |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 4K | $500K+ | SH |
| Bank of New York Mellon Corp | 99K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Saturn V Capital Management LP
SC 13G · Feb 17, 2026
7.0%
3.7M shares
SC 13G · Feb 17, 2026
7.4%
3.9M shares
SC 13G/A · Jan 29, 2025
0.0%
0 shares
SC 13D · Aug 30, 2023
20.0%
3.3M shares
SC 13G/A · Mar 2, 2022
0.0%
0 shares
Altium Capital Management, LP EIN 82-2066653
SC 13G/A · Feb 11, 2022
1.6%
122K shares